2-A1MP
 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral, insufflation |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}} |
| Chemical and physical data | |
| Formula | C13H17NO4 |
| Molar mass | 237.25 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
2-A1MP is a chemical compound in the cathinone family of compounds. It is the beta-ketone version of 5-Methoxy-MDMA.[2][3][4] The more common name 2-AIMP/2-A1MP does not appear to relate to the molecular structure. The two compounds differ by the addition of a MeO group at the 5th carbon atom of the aromatic ring, this addition seems to be responsible for the added potency and visual activity reported by those who have submitted experience reports.[5]
The toxicity of this compound is unknown. There is very little documented info on this substance at this time.
References
- ↑ DEA (July 21, 2015). "Controlled Substances -Alphabetical Order-" (PDF). DEA. Archived from the original (PDF) on April 17, 2016. Retrieved October 16, 2015.
- ↑ CaymanChemical. "5-Methoxy-Methylone (aka 2-a1mp/2-aimp)". Retrieved October 19, 2015.
- ↑ CaymanChemical. "5-Methoxy-Methylone GC/MS data" (PDF). Retrieved October 19, 2015.
- ↑ CaymanChemical. "5-Methoxy-Methylone MSDS" (PDF). Retrieved October 19, 2015.
- ↑ "2-AIMP". October 15, 2015. Retrieved October 16, 2015.
This article "2-A1MP" is from Wikipedia. The list of its authors can be seen in its historical. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
